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Meta-Analysis of Genetic Influences on Initial Alcohol
Sensitivity
Alexis C. Edwards , Joseph D. Deak, Ian R. Gizer, Dongbing Lai, Chris Chatzinakos,
Kirk P. Wilhelmsen, Jonathan Lindsay, Jon Heron, Matthew Hickman, Bradley T. Webb,
Silviu-Alin Bacanu, Tatiana M. Foroud, Kenneth S. Kendler, Danielle M. Dick* , and
Marc A. Schuckit*
Background: Previous studies indicate that low initial sensitivity to alcohol may be a risk factor for
later alcohol misuse. Evidence suggests that initial sensitivity is inﬂuenced by genetic factors, but few
molecular genetic studies have been reported.
Methods: We conducted a meta-analysis of 2 population-based genome-wide association studies of
the Self-Rating of the Eﬀects of Alcohol scale. Our ﬁnal sample consisted of 7,339 individuals (82.3%
of European descent; 59.2% female) who reported having used alcohol at least 5 times. In addition, we
estimated single nucleotide polymorphism (SNP)-based heritability and conducted a series of secondary
aggregate genetic analyses.
Results: No individual locus reached genome-wide signiﬁcance. Gene and set based analyses, both
overall and using tissue-speciﬁc expression data, yielded largely null results, and genes previously impli-
cated in alcohol problems and consumption were overall not associated with initial sensitivity. Only 1
gene set, related to hormone signaling and including core clock genes, survived correction for multiple
testing. A meta-analysis of SNP-based heritability resulted in a modest estimate of h2SNP = 0.19
(SE = 0.10), though this was driven by 1 sample (N = 3,683, h2SNP = 0.36, SE = 0.14, p = 0.04). No sig-
niﬁcant genetic correlations with other relevant outcomes were observed.
Conclusions: Findings yielded only modest support for a genetic component underlying initial alco-
hol sensitivity. Results suggest that its biological underpinnings may diverge somewhat from that of
other alcohol outcomes and may be related to core clock genes or other aspects of hormone signaling.
Larger samples, ideally of prospectively assessed samples, are likely necessary to improve gene identiﬁ-
cation eﬀorts and conﬁrm the current ﬁndings.
Key Words: Avon Longitudinal Study of Parents and Children, Genetics, Genome-Wide
Association Studies, Heritability, Initial Alcohol Sensitivity, Self-Rating of the Eﬀects of Alcohol.
ALCOHOL MISUSE IS a common and costly humanbehavior, accounting for 3.3 million deaths worldwide
in 2012 (World Health Organization, 2014) and over $220
billion in annual economic tolls in the United States alone
(Bouchery et al., 2011). Alcohol-related outcomes are
inﬂuenced by genetic factors: The heritability of alcohol use
disorder (AUD) was estimated at 0.50 in a meta-analysis of
twin studies (Verhulst et al., 2015), and recent genome-wide
association studies (GWAS) of alcohol consumption and
symptoms have reported single nucleotide polymorphism
(SNP)-based heritabilities of 0.13 (Clarke et al., 2017) and
0.12 (Sanchez-Roige et al., 2017), respectively. Variation in
genes involved in alcohol metabolism (e.g., alcohol and alde-
hyde dehydrogenases) is known to impact liability to prob-
lems (Edenberg, 2007) and consumption (Jorgenson et al.,
2017); there is support for a role of genes outside of this
metabolic pathway as well (Schumann et al., 2011, 2016).
However, much remains unclear about the mechanisms
underlying genetic inﬂuences on alcohol outcomes, necessi-
tating further study and consideration of precursors in addi-
tion to the outcomes themselves.
Sensitivity to alcohol’s eﬀects, particularly during initia-
tion of voluntary alcohol consumption, has been associated
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with later alcohol use and misuse (Schuckit, 1994; Schuckit
et al., 2008a,b). Under a model in which an individual con-
sumes alcohol in part to experience its pleasant physiological
eﬀects (e.g., a “buzz”), it follows that those who are less sen-
sitive to these eﬀects will consume more than their peers
(Trela et al., 2016). Higher consumption, in turn, is posi-
tively associated with alcohol problems (Barnett et al., 2014;
Dick et al., 2011; Heath et al., 1999; Schuckit et al., 2007) in
some but not all (Heath et al., 1999) studies, raising the pos-
sibility that those whose subjective response to alcohol is low
have higher liability to later misuse.
The Self-Rating of the Eﬀects of Alcohol (SRE) scale was
developed by Schuckit and colleagues (1997) to operational-
ize an individual’s alcohol sensitivity by quantifying the
number of standard alcoholic drinks necessary to experience
physiological eﬀects of alcohol, such as dizziness and slur-
ring; it does not capture all dimensions of intoxication.
Higher scores reﬂect the need to consume a higher volume of
alcohol to experience those eﬀects—that is, lower sensitivity
to alcohol per drink. Importantly, there is evidence that this
sensitivity is heritable: Individuals with a family history of
alcohol problems exhibit less pronounced alcohol sensitivity
(Schuckit, 1980, 1984; Schuckit et al., 1996, 2000, 2003)
across a variety of assessments, including the SRE (Schuckit
et al., 2003). We are aware of only 1 twin study of alcohol
response (Heath et al., 1999) in adulthood, which reported a
heritability of 0.6. Furthermore, linkage studies have identi-
ﬁed loci associated with SRE (Ehlers et al., 2010; Schuckit
et al., 2001), and variants in GABRA2 were nominally asso-
ciated with both subjective and objective measures of alcohol
sensitivity in an Australian sample (Lind et al., 2008). A vari-
ety of gene sets are hypothesized to inﬂuence alcohol sensitiv-
ity (Schuckit, 2018), but in the absence of molecular genetic
analyses, these remain speculative.
The current study aimed to expand information available
on genetic inﬂuences underlying initial sensitivity to alcohol.
We conducted a meta-analysis of GWAS on SRE scores from
2 independent, population-based cohorts. While both samples
are predominantly of European (EUR) descent, 1 sample also
included individuals of African (AFR) and American (AMR)
descent. By elucidating the biological underpinnings of initial
sensitivity to alcohol, we can improve existing models of
mechanisms underlying risk of alcohol misuse and potentially
inform personalized intervention and prevention program-
ming that might be used even before the ﬁrst drink.
MATERIALS ANDMETHODS
Samples
Avon Longitudinal Study of Parents and Children. We used 2
population-based cohort samples: the Avon Longitudinal Study of
Parents and Children (ALSPAC) and Spit for Science (S4S).
ALSPAC recruited 14,541 pregnant women residing in Avon, UK,
with expected dates of delivery April 1, 1991, to December 31, 1992;
14,541 is the initial number of pregnancies for which the mothers
enrolled in the ALSPAC study and had either returned at least 1
questionnaire or attended a “Children in Focus” clinic by July 19,
1999. Of these initial pregnancies, there were a total of 14,062 live
births and 13,988 children who were alive at 1 year of age. Subsequent
phases of enrollment increased the sample size over time. The phases
of enrollment are described in more detail elsewhere (Boyd et al.,
2013; Fraser et al., 2013). For the current analyses, full or partial phe-
notypic data were available for 5,626 participants, in part reﬂecting
the need for a subject to have had experience with alcohol in order to
ﬁll out the SRE. The study website contains details of all the data that
is available through a fully searchable data dictionary (http://www.b
ris.ac.uk/alspac/researchers/data-access/data-dictionary/). Ethical
approval for the study was obtained from the ALSPAC Ethics and
Law Committee and the Local Research Ethics Committees.
Spit for Science. S4S is an ongoing longitudinal study of college
students enrolled in a large, urban university in the mid-Atlantic
(Dick et al., 2014). Brieﬂy, incoming students age 18 or older were
eligible to complete phenotypic assessments, which covered a wide
range of topics but focused on alcohol use. Study data were col-
lected and managed using REDCap electronic data capture tools
(Harris et al., 2009) hosted at Virginia Commonwealth University.
Follow-up assessments were completed in subsequent spring seme-
sters. Individuals who did not participate in the ﬁrst wave of data
collection (including those who turned 18 after the end of the ﬁrst
wave of data collection) had the opportunity to join the study the
following spring; those who participated during their ﬁrst year were
eligible to complete follow-up assessments each spring. Participants
who completed the phenotypic assessments were eligible to provide
a DNA sample. The current study includes 3 cohorts, which matric-
ulated in Fall 2011 (N = 2,714), 2012 (N = 2,486), and 2013
(N = 2,403), for a total N = 7,603. Ethical approval was obtained
from the local Institutional Review Board.
Phenotypes
Outcome. The SRE consists of 4 items; for the current study,
each item referred to the first 5 or so times a participant used alco-
hol. Participants were asked to report the number of standard
drinks they consumed before they experienced signs of alcohol’s
eﬀect (from feeling any eﬀect of the alcohol on to slurring words,
feeling unsteady on their feet, to unwanted falling asleep). Consis-
tent with prior papers, responses were winsorized to limit extreme
values and reduce the eﬀect of possibly spurious outliers. SRE
scores were calculated by summing drinks needed for eﬀects across
items and dividing by the number of the eﬀects experienced (i.e., the
4 items that the participant could have experienced), as recom-
mended by Schuckit and colleagues (1997). The ﬁnal score was used
as a continuous outcome in subsequent GWAS.
Both ALSPAC and S4S participants were administered the SRE
items across multiple assessments. For ALSPAC, we examined data
from questionnaires/clinic visits at average ages 15.5, 16.5, and 17.5.
S4S participants were administered the SRE items at average ages
18.5, 19.0, 19.9, and 21.0. For both samples, only participants who
reported having initiated alcohol use were administered the SRE
items; others were coded as “NA.”Where scores were available for a
participant across multiple waves, the ﬁrst score was used for
GWAS, reasoning that this wave represented the assessment most
temporally proximal to the initiation of alcohol use and was there-
fore least susceptible to recall bias. The size of a standard drink, to
which respondents are asked to refer when completing the SRE
items, diﬀers in the United States and the United Kingdom (14 g vs.
8 g of ethanol [EtOH], respectively). Therefore, raw SRE scores were
standardized for GWAS analyses, ensuring that eﬀect sizes observed
across the ALSPAC and S4S samples were on the same scale.
Covariates. Sex was included as a covariate (individuals whose
self-reported gender was inconsistent with genetic sex were excluded
from these analyses) in initial GWAS within both samples. For
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ALSPAC, wave at which the SRE items were ﬁrst completed was
included as a covariate; assessments are age-standardized but pre-
cise date of completion was unavailable. For S4S, age at which the
SRE items were ﬁrst completed was included as a covariate (mean
[SD] age across all samples = 18.80 [0.79]). To account for popula-
tion structure, 10 ancestry-informative principal components (PCs)
were included in the ALSPAC GWAS, consistent with prior analy-
ses using this sample (Edwards et al., 2017). S4S participants are of
diverse ancestry and were ﬁrst assigned to empirically based ances-
try groups using PCs derived from 1000 Genomes (phase 3) refer-
ence populations, as described by Peterson and colleagues (2017).
Subsequently, within-ancestry PCs were calculated to capture ﬁne-
grained stratiﬁcation; PCs were retained as covariates in the GWAS
using a stepwise regression approach.
Imputation and Quality Control Filters
Imputed genotypes for both samples were derived using the 1000
Genomes reference panels as previously reported (Edwards et al.,
2017; Webb et al., 2017). Quality control procedures for genetic
analyses of both the ALSPAC and S4S samples have been previ-
ously described (Fatemifar et al., 2013; Webb et al., 2017), and
those within-sample approaches were applied for the current analy-
ses (see Appendix S1). Brieﬂy, individual DNA samples and mark-
ers were excluded based on excess missingness (>5% for both
samples), deviations from Hardy–Weinberg equilibrium (p < 5e-7
for ALSPAC, p < 5e-6 for S4S), and minor allele frequency (MAF;
<0.01 for ALSPAC, <0.005 for S4S). Cryptic relatedness was calcu-
lated using pi-hat, and related individuals were excluded.
Genetic Analyses
GWAS and Meta-Analysis. For ALSPAC, phenotypic (includ-
ing outcome and covariate) and genetic data were available for
3,683 individuals, all of EUR ancestry. GWAS was run in Plink 1.9
(Chang et al., 2015). For S4S, we included only groups with
N ≥ 400 to reduce the likelihood of spurious results, yielding the fol-
lowing sample sizes: AFR = 892; AMR = 408; and EUR = 2,356
(total S4SN = 3,656). The S4S GWAS were run in SNPTest version
2.5.2 (Marchini et al., 2007), separately by ancestry group, as
described previously. Results across samples (total N = 7,339) were
meta-analyzed using METAL (Willer et al., 2010), using inverse
variance weighting by sample size. Markers with MAF < 0.01
within sample/ancestry group and/or INFO < 0.5 were excluded
from further analysis.
Gene and Gene Set Analyses. We applied 2 approaches to gene
and set based analyses, FUMA (Watanabe et al., 2017) and
JEPEGMIX (Lee et al., 2016). The former conducts gene-based
tests across all markers followed by gene set analysis. We submitted
meta-analysis summary statistics to the FUMA pipeline, which
requires selection of a reference panel in order to account for linkage
disequilibrium (LD) among markers. We selected the EUR subsam-
ple of the 1000 Genomes reference panel as this group constituted
>82% of the sample, and correcting for EUR LD is a more conser-
vative approach than correcting for AFR LD (AFR being the next-
largest component of the full sample). JEPEGMIX diﬀers from
FUMA in that its gene and set based analyses are tissue speciﬁc:
Using GWAS summary statistics, it tests the joint eﬀect of func-
tional SNPs known to aﬀect the expression of a gene, eﬀectively pre-
dicting whether tissue-speciﬁc gene expression is associated with an
outcome of interest (here, SRE score). The method can be extended
to estimate the joint eﬀects across gene sets.
Heritability and Genetic Correlations. GCTA (Yang et al.,
2011) was used to assess SNP-based heritability (h2SNP). Analyses
were conducted within group (ALSPAC, AFR, AMR, and EUR),
using unrelated individuals and markers with MAF ≥ 0.01. To
assess genetic correlations between SRE and other relevant traits
assessed in independent samples, summary statistics were uploaded
to LDHub (Zheng et al., 2017). We tested whether SRE was geneti-
cally correlated with traits in selected categories: anthropometric,
brain volume, cognitive, education, hormone, metabolites, person-
ality, psychiatric, reproductive, and smoking behaviors.
Polygenic Risk Scores. Polygenic risk scores (PRS) were derived
to test whether aggregate risk for SRE in the discovery set was asso-
ciated with phenotype in the test set. We used weights from 2 discov-
ery sets: (i) the full meta-analysis; and (ii) the ALSPAC-speciﬁc
results, given evidence of heritability in ALSPAC but not S4S. The
ﬁrst test set involved participants (N = 1,080; 61.1% male) with both
genotype and phenotype data from the UCSF Family Alcoholism
Study (Vieten et al., 2004). The sample was composed of small fam-
ily pedigrees, which ranged in size from 3 to 20 individuals. The sub-
sample used in the present study had an average age of 48.9
(SD = 12.1) years. PLINK 1.9 (Chang et al., 2015) was used to
derive PRS. We employed a linear mixed model with a kinship
matrix ﬁtted as a random eﬀect to control for the relatedness among
participants. Age, sex, and 4 ancestry PCs were included as covari-
ates. The second data set was from the Collaborative Study on the
Genetics of Alcoholism (COGA). COGA is a multicenter study of
families with alcohol dependence. African American (AA) and Euro-
pean American (EA) subsamples of COGA were included in analy-
sis. For each COGA subsample, all individuals (N = 1,527 in AA;
N = 4,717 in EA) and COGA prospective samples (N = 326 in AA;
N = 822 in EA), which were oﬀspring of COGA families that were
born after 1982 (Bucholz et al., 2017) to match the ALSPAC/S4S
samples, were tested separately. PRSice-2 (Euesden et al., 2015) was
used to calculate PRS. Sex, the ﬁrst 4 ancestry PCs, and genotyping
array indicators were included as covariates. For analyses of all indi-
viduals, birth cohorts were also included as covariates. Linear mixed
models were ﬁt to adjust family clustering using SAS9.4 (SAS Insti-
tute Inc., Cary, NC). For both the UCSF and COGA samples, we
tested for associations at 8 p-value thresholds: 0.001, 0.01, 0.05, 0.1,
0.2, 0.3, 0.4, and 0.5.
RESULTS
Descriptive Statistics
Descriptive statistics of the sample, including mean SRE
scores by group prior to transformation, are provided in
Table 1. Scores were signiﬁcantly higher in the S4S sample
relative to ALSPAC (t = 7.49, p < 0.0001). Diﬀerences
were also observed across S4S ancestry groups, F(2,
3,653) = 10.12, p < 0.0001. Men’s scores were higher than
women’s (t = 20.51, p < 0.0001). SRE scores were moder-
ately correlated with later alcohol consumption (r = 0.20 to
0.25 in S4S; r = 0.18 to 0.28 in ALSPAC; all p < 0.0001),
which was operationalized in S4S as grams of EtOH per
month (derived from responses to alcohol use frequency and
quantity; Salvatore et al., 2016) and in ALSPAC as Alcohol
Use Disorders Identiﬁcation Test-Consumption (AUDIT-C)
scores (Bush et al., 1998).
Meta-Analysis of GWAS Results
Results from the meta-analysis of SRE scores are dis-
played in Figs 1 and 2. In each group-level analysis and in
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the meta-analysis, there was no evidence of inﬂation due to
population stratiﬁcation (k1000 = 0.99 to 1.00). A total of
15,642,250 markers were analyzed in the meta-analysis;
10,752,408 were assessed in at least 1,000 individuals. No
individual locus met genome-wide signiﬁcance criteria
(p < 5 9 108). The top marker was rs146298733
(p = 3.16 9 107), which maps to an intron in DLGAP1 on
chromosome 18; this result may be spurious as surrounding
markers do not have similar p-values. The minor allele was
only of suﬃcient frequency to test in the ALSPAC and EUR
groups (N = 6,039; MAF = 0.02 in both samples).
Meta-analysis summary statistics were uploaded to
FUMA, which identiﬁed 35 lead SNPs based on p-value and
LD; these are presented in Table 2 alongside functional
information derived from Combined Annotation Dependent
Depletion (CADD; Kircher et al., 2014) scores and
RegulomeDB (Boyle et al., 2012). Overall, these markers are
not predicted to be especially deleterious—only 1 marker has
a CADD score >10—nor are they predicted to have mean-
ingful regulatory roles—no marker has a RegulomeDB score
of 1a to 1f.
Gene and Gene Set Analyses
Using FUMA, markers were mapped to 18,363 protein
coding genes; none met genome-wide signiﬁcance criteria
(p < 2.72 9 106). Complete results are available in
Table S1, while the top 10 genes are listed in Table 3. The
FUMA pipeline also uses the complete distribution of SNP
p-values to conduct a gene set analysis (Nset = 10,891) using
MSigDB (Subramanian et al., 2005). Only 1 gene set had a
corrected p-value of <0.05: regulation of intracellular steroid
hormone receptor signaling pathway (Table 4; corrected
p = 0.03). Complete results are available in Table S2.
Using JEPEGMIX, we assessed whether tissue-speciﬁc
expression for individual genes was predicted to be associ-
ated with SRE scores. No gene met the corrected signiﬁcance
threshold (Table S3). We next tested whether expression
levels of genes in canonical gene sets were jointly predicted to
be associated with SRE scores. No gene set met the corrected
signiﬁcance threshold (Table S4).
Heritability, Genetic Correlations, and PRS
Heritability estimates for each S4S ancestry group were
not signiﬁcantly diﬀerent from 0 (h2SNP<0.001; SE = 0.16 to
0.59; p = 0.13 to 0.50). However, for ALSPAC, heritability
was moderate (h2SNP = 0.36, SE = 0.14, p = 0.04). Although
the meta-analytic h2SNP was diﬀerent from 0 (h
2
SNP = 0.19,






Effects of Alcohol score
Sample
Combined 7,339 17.4 (1.58)a 5.30 (2.54)
ALSPAC 3,683 16.03 (0.74)a 5.08 (2.75)
S4S 3,656 18.78 (0.79) 5.53 (2.29)
African 892 18.82 (0.80) 5.24 (2.41)
American 408 18.76 (0.89) 5.77 (2.43)
European 2,356 18.78 (0.77) 5.59 (2.21)
Sex
Women 4,347 17.45 (1.54) 4.81 (2.31)
Men 2,992 17.33 (1.62) 6.02 (2.70)
aBecause precise ages were not available for Avon Longitudinal Study
of Parents and Children (ALSPAC) participants, expected average age for
the wave of data collection was used for these values.
Fig. 1. Manhattan plot of Self-Rating of the Effects of Alcohol scores for
markers assessed in at least 1,000 individuals. Red line indicates genome-
wide significance threshold (p < 5 9 108); blue line indicates suggestive
significance (p < 1 9 10-5).
Fig. 2. Quantile–quantile plot for each sample, as well as for meta-
analysis results for markers assessed in at least 1,000 individuals.
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SE = 0.10), this was clearly driven by the ALSPAC group.
Because h2SNP exceeded 0 only in the ALSPAC sample, only
ALSPAC-speciﬁc summary statistics (i.e., not the meta-ana-
lytic results) were uploaded to LD Hub. There were no sig-
niﬁcant genetic correlations between SRE and any of the
traits assessed in LD Hub, though we note that the mean v2
(1.005) was ﬂagged by the program as potentially too low.
Complete results are available in Table S5. We also
conducted bivariate GCTA between SRE and AUDIT-C
and total scores at ages 16, 18, and 21; these analyses were
limited to ALSPAC given null h2SNP estimates in S4S. Genetic
correlations were not signiﬁcant, but were largely positive
(rGSNP = 0.55 to 1.00) with 1 exception (SRE and age 21
AUDIT-C, rGSNP = 0.07, n.s.). Finally, we tested whether
markers implicated at 8 p-value thresholds in the meta-analy-
sis were associated with SRE scores in 2 independent sam-
ples. We derived the PRS using meta-analysis SNP weights
and using ALSPAC-speciﬁc weights, due to the detection of
signiﬁcant h2SNP in ALSPAC but not S4S groups. We
observed several nominally signiﬁcant associations
(0.01 < p < 0.05) but no systematic eﬀects.
DISCUSSION
Initial sensitivity to the eﬀects of alcohol has been associ-
ated, in the ALSPAC sample (Schuckit et al., 2008a,b)
among others, with later alcohol misuse and problems, such
that individuals less sensitive to alcohol when they begin
drinking are at higher risk of later misuse. Evidence from
twin and family studies, alongside preliminary ﬁndings from
gene identiﬁcation eﬀorts, has suggested that the association
Table 2. Lead SNPs from Functional Mapping and Annotation of Genome-Wide Association Studies (FUMA) and Corresponding Functional Annotation
rsID Chr Position p-Value Nearest gene Distance from gene Function CADD score RDB
rs145005509 1 244472953 5.73E-06 C1orf100 42,984 intergenic 11.47 7
rs10788734 1 248075398 6.26E-06 OR2T8 8,922 intergenic 1.717 7
rs72806266 2 59501865 7.42E-06 ENSG00000233891 0 ncRNA_intronic 0.442 6
rs112834343 2 224599695 7.22E-07 AP1S3 16,708 intergenic 4.525 6
rs17033567 3 10913738 5.65E-06 SLC6A11 0 intronic 2.597 7
rs2336522 3 22023520 5.40E-06 ZNF385D-AS2 2,200 intergenic 0.718 7
rs112368179 3 133217908 8.09E-06 ENSG00000214301 7,559 intergenic 5.85 5
rs75536499 4 536426 6.58E-07 PIGG 3,108 intergenic 0.127 5
rs115496994 4 86353705 6.92E-06 ARHGAP24 42,562 intergenic 7.664 7
rs10020261 4 184171187 2.57E-06 WWC2 0 intronic 8.42 4
rs4869281 5 95651353 6.84E-06 CTD-2337A12.1 0 ncRNA_intronic 3.662 3a
rs75886551 6 51028172 8.77E-06 FTH1P5 147,203 intergenic 0.435 4
rs11465543 6 52108584 2.41E-06 IL17F 0 intronic 2.813 NA
rs76563242 6 88277132 3.24E-06 RARS2 0 intronic 0.719 7
rs62421504 6 113654797 5.24E-06 ENSG00000223811 23,408 intergenic 0.663 7
rs206972 6 167689552 3.11E-06 UNC93A 0 intronic 0.043 6
rs73133463 7 55119501 9.18E-06 EGFR 0 intronic 3.336 5
rs2100160 8 427140 5.35E-06 ENSG00000272005 0 ncRNA_exonic 0.355 NA
rs16905012 8 134905738 8.65E-06 RP11-157E21.1 0 ncRNA_intronic 4.592 7
rs11777857 8 138546064 3.35E-06 ENSG00000254076 162,903 intergenic 3.359 5
rs28373932 9 139998042 4.94E-06 MAN1B1 0 intronic 4.023 5
rs76238752 10 16614401 3.30E-06 RSU1 18,209 intergenic 6.354 7
rs10825405 10 56592865 7.00E-06 PCDH15 0 intronic 1.107 5
rs75752490 10 67293784 3.05E-06 ENSG00000228065 36,312 intergenic 5.932 6
rs61866256 10 85682627 5.53E-07 ENSG00000233258 9,949 intergenic 4.181 7
rs7076325 10 101868347 5.73E-06 TPM4P1 5,827 intergenic 0.899 6
rs184338590 10 109779481 4.11E-06 RP11-215N21.1 0 ncRNA_intronic 3.103 7
rs75794081 11 71069255 5.39E-06 AP002387.1 24,392 intergenic 1.829 5
rs41287003 13 41910631 9.71E-06 NAA16 0 intronic 5.577 7
rs9547398 13 86417640 3.01E-06 SLITRK6 44,017 intergenic 2.744 7
rs1016246 14 26679400 2.42E-06 CYB5AP5 1,770 intergenic 2.935 NA
rs116879015 15 45492952 1.51E-06 SHF 0 exonic 7.285 4
rs146087183 16 57934080 2.83E-06 CNGB1 0 intronic 1.436 4
rs7214066 17 4678855 3.89E-06 TM4SF5 0 intronic 2.927 7
rs146298733 18 4114529 3.16E-07 DLGAP1 0 intronic 2.39 7
Chr, chromosome; CADD, Combined Annotation Dependent Depletion; RDB, RegulomeDB; SNP, single nucleotide polymorphism.
Table 3. Top 10 Gene-Based Results From FUMA
Symbol Chr Start BP End BP N SNPs Z statistic p-Value
ZBTB44 11 130086572 130194581 397 4.2267 1.19e-05
BHLHE40 3 5010801 5037008 88 4.2012 1.33e-05
ISL1 5 50668921 50700564 77 3.8686 5.47e-05
NDNF 4 121946768 122004176 193 3.6830 1.15e-04
ACTN4 19 39128289 39232223 370 3.5510 1.92e-04
C1orf122 1 38262651 38285126 42 3.5426 1.98e-04
CYSLTR2 13 49270951 49293498 83 3.5399 2.00e-04
ATG4D 19 10644571 10674094 113 3.5359 2.03e-04
TMIGD1 17 28633351 28671077 90 3.4772 2.53e-04
FAM159A 1 53089016 53145355 181 3.4280 3.04e-04
Chr, chromosome; BP, base pair; N SNPs, number of single nucleotide
polymorphisms.
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may be due in part to genetic inﬂuences on sensitivity. In the
current study, we meta-analyzed GWAS of initial sensitivity
to alcohol, using the ﬁrst 5 times drinking SRE scale in 2
large, population-based samples. Analyses yielded few gen-
ome-wide signiﬁcant ﬁndings, and PRS were not consistently
associated with SRE in 2 independent samples. Our limited
positive results came from aggregate tests, which indicated
moderate heritability (overall h2SNP = 0.19, SE = 0.10) and
support for a role of genes involved in hormone signaling.
Initial alcohol sensitivity may be more prominently environ-
mentally inﬂuenced than previously thought. However, stud-
ies of other behavioral outcomes with heritable components
have yielded null results until much larger sample sizes were
amassed (e.g., Wray et al., 2018). Follow-up is warranted,
preferably using samples assessed during adolescence, con-
temporaneous with initial alcohol use. Furthermore, assess-
ment of multiple ancestry groups is critical for clarifying the
extent to which phenotypic diﬀerences are inﬂuenced by
genetic factors.
Although no marker met genome-wide signiﬁcance crite-
ria, this is not entirely unexpected given evidence that sub-
stantially larger sample sizes may be necessary to reliably
identify loci of small eﬀect in complex traits (Bacanu and
Kendler, 2018; Sullivan et al., 2017). Suggestive loci localize
to several genes of interest. For example, SLC6A11 is a
GABA transporter preferentially expressed in brain (Fager-
berg et al., 2014); variation in this gene has been associated
with intellectual and behavioral aberrations (Dikow et al.,
2014) and resistance to epilepsy pharmacotherapy (Kim
et al., 2011). Given the role of the GABAergic system in
alcohol response and sensitization (Camarini and Pautassi,
2016; Koob, 2013), the biological plausibility of SLC6A11 is
compelling. While other GABAergic genes involved in alco-
hol-relevant processes had suggestive p-values (e.g.,
GABARAP, p = 0.003; GABRB3, p = 0.001), these did not
survive a multiple testing correction. Genes implicated in
recent large GWAS of alcohol-related outcomes (Clarke
et al., 2017; Jorgenson et al., 2017; Sanchez-Roige et al.,
2017; Schumann et al., 2016) were also not supported.
Indeed, no locus implicated by lead SNPs or gene-based
analyses has been previously associated with alcohol use/mis-
use; these novel candidates require further investigation to
determine the mechanisms by which they may inﬂuence alco-
hol sensitivity. However, the dearth of loci meeting strict cor-
rection thresholds prevents extensive interpretation of the
current ﬁndings.
As indicated by CADD scores, lead SNPs are overall not
predicted to be deleterious. Only rs145005509 has a CADD
score >10; this SNP is intronic to a predicted locus and
upstream of an open reading frame, thus, its functional sig-
niﬁcance is unclear. Importantly, we evaluated only common
alleles, which are relatively infrequently deleterious. Perhaps
more interestingly, lead SNPs are not predicted to have clear
regulatory functions, in contrast with ﬁndings for
schizophrenia (Roussos et al., 2014), major depression
(Wray et al., 2018), and nicotine dependence (Zanger and
Schwab, 2013). RegulomeDB annotations were only
obtained for lead SNPs through the FUMA pipeline, leaving
open the possibility that less strongly implicated markers
have regulatory functions.
One gene set survived the multiple test correction thresh-
old (regulation of intracellular steroid hormone reception sig-
naling pathway), and scrutiny of the genes in that category
(obtained from MSigDB) revealed a potentially interesting
avenue for further inquiry: They include core clock genes
involved in circadian rhythms and/or photoperiodism, which
were among the top 10 most strongly implicated gene sets
(Table S2). Genes included in all 3 sets are CLOCK, CRY1,
CRY2, and PER1; other clock genes are common to 2 of the
3 sets. CLOCK and PER1 have been associated with AUDs
(Partonen, 2015), and there is evidence that clock genes may
have a regulatory role in reward circuitry (Parekh et al.,
2015). Furthermore, mice with various perturbations in clock
genes exhibit aberrant alcohol-related phenotypes (Dong
et al., 2011; Gamsby et al., 2013; Perreau-Lenz et al., 2009;
Spanagel et al., 2005; Wang et al., 2012).
The heritability of SRE scores in ALSPAC was moderate
(h2SNP = 0.36) and diﬀered signiﬁcantly from 0, suggesting
that aggregate genetic factors contribute substantially to ini-
tial alcohol sensitivity. However, the heritability estimates
were eﬀectively 0 for each S4S ancestry group. This pro-
nounced diﬀerence may be due in part to assessment.
ALSPAC participants were periodically assessed in the time
frame during which they were likely to begin experimenting
Table 4. Top 10 Gene Set Based Results from FUMA
Full set name N genes Beta Beta SD SE p-Value
GO bp:go regulation of intracellular steroid hormone receptor signaling pathway 57 0.4570 0.0254 0.1000 2.51e-06
Curated gene sets:dasu il6 signaling up 58 0.4140 0.0232 0.1030 2.89e-05
GO bp:go regulation of metal ion transport 315 0.1770 0.0229 0.0444 3.41e-05
Curated gene sets:kegg circadian rhythmmammal 13 0.7670 0.0204 0.1930 3.47e-05
GO bp:go regulation of cell proliferation involved in heart morphogenesis 15 0.9090 0.0260 0.2300 4.00e-05
GO bp:go cell-cell recognition 59 0.3640 0.0206 0.0943 5.73e-05
GO bp:go protein alpha 1 2 demannosylation 13 0.7530 0.0200 0.2040 1.13e-04
GO bp:go protein demannosylation 13 0.7530 0.0200 0.2040 1.13e-04
GO bp:go positive regulation of hydrolase activity 872 0.0995 0.0212 0.0271 1.22e-04
GO bp:go photoperiodism 23 0.5170 0.0183 0.1420 1.40e-04
GO, gene ontology; bp, biological process; SD, standard deviation; SE, standard error
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with alcohol: While 62% responded to SRE items in wave 1
(age ~15.5), the remainder had not used alcohol 5 or more
times until a later assessment. In contrast, 79% of S4S partic-
ipants’ reports were from wave 1 (age ~18.5) and it is likely
that many were reporting on alcohol exposure several years
in the past. This raises the possibility that the scores are quite
sensitive to recall bias. Thus, it is unclear whether the null
heritability estimates of SRE across S4S ancestry groups are
due to a true absence of genetic inﬂuences on SRE in S4S,
potential error introduced by retrospective reports, or other
factors. We are further unable to determine whether ances-
try-based diﬀerences in heritability exist.
Additional tests of aggregate genetic inﬂuences did not
yield signiﬁcant ﬁndings. The absence of association between
PRS derived from meta-analysis and ALSPAC-speciﬁc SNP
weights and SRE scores in independent samples could be due
to assessment, that is, recall bias within the older individuals
in the samples. However, we cannot rule out the possibility
that the signals from our GWAS were of insuﬃcient preci-
sion for outcome prediction, or that nongenetic factors are
simply more inﬂuential than genetic factors on initial alcohol
sensitivity.
The analyses presented here suggest that genetic factors
have a modest impact on initial sensitivity to alcohol, but are
largely inconclusive with respect to underlying biology. This
underscores the need for prospective assessments of large,
diverse samples to clarify the biological mechanisms underly-
ing alcohol sensitivity and how they may diﬀer across ances-
tries. Prior evidence that low initial sensitivity is associated
with later alcohol misuse (Barnett et al., 2014; Heath et al.,
1999; Schuckit, 1994) suggests that SRE scores could be a
useful risk indicator. Further elucidation of the biological
processes impacting initial sensitivity is necessary and could
be accomplished in part by characterizing loci implicated in
the current study in model systems to determine whether,
and how, genetic manipulations eﬀect EtOH sensitivity.
Another avenue for potential research is the identiﬁcation of
speciﬁc environmental factors that account for the balance
of phenotypic variance in SRE scores; examples may include
diet, pubertal status, or psychological stressors with physio-
logical consequences. While we understand a great deal
about alcohol metabolism via alcohol dehydrogenases and
other pathways (Lieber, 2005; Marshall and Chambers,
2005), the subjective experience of drinkers is likely inﬂu-
enced by a wider range of genetic factors, the identiﬁcation
of which is critical to developing a comprehensive model of
risk.
Limitations
Despite this being the largest genetic study of initial alco-
hol sensitivity to date, it is possible that the retrospective
SRE assessment in approximately half of the total sample
compromised our statistical power to detect inﬂuential loci.
Individuals in both samples for whommultiple waves of data
were available generally reported increasing SRE scores in
later assessments despite the reporting period being constant
(i.e., the ﬁrst 5 or so times they drank alcohol); this raises the
possibility that current drinking experiences inﬂuence report-
ing of past sensitivity. This may have contributed to the dis-
crepancy in h2SNP estimates across the ALSPAC and S4S
samples. The moderate estimate in ALSPAC encourages us
that genetic factors are, indeed, inﬂuential, though power
analyses indicated <10% power to detect a h2SNP of 0.30 in
the smallest S4S subgroup, AMR. The EUR samples were
more adequately powered: In ALSPAC, we estimated 64%
power to detect h2SNP of 0.20 and 99% power to detect h
2
SNP
of 0.36 (the actual estimate), and 61% power to detect h2SNP
of 0.30 the S4S EUR ancestry group. Despite the lack of gen-
ome-wide signiﬁcant variants, the current report represents
an important initial eﬀort to improve our understanding of
the biological underpinnings of alcohol sensitivity.
Genetic studies are frequently limited to samples of EUR
ancestry, precluding opportunities to assess diﬀerential genetic
eﬀects across ancestry groups. Although this study included a
diverse sample, the non-EUR groups were of modest sample
size and we lacked suﬃcient power to directly test such eﬀects.
However, eﬀorts to recruit diverse samples are increasing, and
meta-analytic approaches will enable the current samples to
be incorporated into larger analyses in the future. Results
from such approaches raise issues regarding the incorporation
of LD in various secondary analyses; here, we elected to use
EUR LD for FUMA, as this is likely a conservative approach
and is appropriate for the majority (>82%) of the sample, but
other methods may be preferable. JEPEGMIX was designed
to be robust to the inclusion of cosmopolitan samples.
Finally, genetic analyses have consistently beneﬁtted from
larger sample sizes. Here, we report initial progress toward
the identiﬁcation of genetic factors inﬂuencing alcohol sensi-
tivity, but these eﬀorts must be bolstered by combining data
across samples to increase statistical power. Given its ease of
use and evidence of validity, the SRE represents a potentially
powerful tool to employ to that end. However, the SRE does
not capture all dimensions of alcohol sensitivity, and the sub-
jective nature of the measure introduces uncertainty into
analyses that are sensitive to measurement error, as is the
case for most complex behavioral traits. Studies of more
objective measures, such as body sway or motor coordina-
tion, would complement studies employing the SRE.
In conclusion, we report evidence of modest genetic inﬂu-
ences on initial sensitivity to alcohol. Suggestive loci have
not been previously implicated in alcohol outcomes, suggest-
ing that the biology of sensitivity is not entirely parallel to
that of alcohol consumption or problems. However, gene set
analysis supports a role for core clock genes in initial sensitiv-
ity. Assessment of sensitivity is likely superior when con-
ducted temporally proximal to initial alcohol
experimentation; ideally, future studies will involve diverse
samples such as that included here. Further investigation of
loci identiﬁed in the current study is warranted to determine
their impact and optimally arrange them in a comprehensive
model of risk for alcohol misuse.
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